• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    NYSE Content Advisory: Pre-Market update + Wall Street braces for Nvidia's earnings

    8/27/25 8:55:00 AM ET
    $ABT
    $ICE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Bankers/Brokers/Service
    Finance
    Get the next $ABT alert in real time by email

    NEW YORK, Aug. 27, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 

    Ashley Mastronardi delivers the pre-market update on August 27th

    • Equities are up this morning as investors wait for chip giant Nvidia's Q2 earnings report. The company is set to release the earnings after market close this afternoon.
    • As the most heavily weighted company in the S&P 500 at more than 8%, Nvidia's results will likely be felt by investors throughout the rest of the week and provide insight into the level of demand for AI.
    • The major averages are coming off a day of fractional gains with investors shaking off President Trump's move to fire Fed Governor Lisa Cook ahead of the Fed's next policy meeting in Mid-September.

    Opening Bell

    Abbott (NYSE:ABT) and the Big Ten Conference are teaming up to address the worst blood shortage in a generation

    Closing Bell

    Van Eck celebrates the 70th anniversary of Van Eck and its first ETF listing

    Click here to download the NYSE TV App

    NYSE Logo (PRNewsfoto/New York Stock Exchange)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-advisory-pre-market-update--wall-street-braces-for-nvidias-earnings-302539974.html

    SOURCE New York Stock Exchange

    Get the next $ABT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABT
    $ICE

    CompanyDatePrice TargetRatingAnalyst
    Intercontinental Exchange Inc.
    $ICE
    3/6/2026$188.00Hold → Buy
    Deutsche Bank
    Intercontinental Exchange Inc.
    $ICE
    10/13/2025$210.00Outperform → Strong Buy
    Raymond James
    Abbott Laboratories
    $ABT
    10/10/2025$145.00Buy
    The Benchmark Company
    Abbott Laboratories
    $ABT
    7/18/2025$145.00Hold → Buy
    Jefferies
    Abbott Laboratories
    $ABT
    6/16/2025$143.00Market Perform
    Leerink Partners
    Intercontinental Exchange Inc.
    $ICE
    10/14/2024$185.00Strong Buy → Outperform
    Raymond James
    Abbott Laboratories
    $ABT
    10/8/2024$130.00Outperform
    Oppenheimer
    Intercontinental Exchange Inc.
    $ICE
    9/27/2024$200.00Outperform
    RBC Capital Mkts
    More analyst ratings

    $ABT
    $ICE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Intercontinental Exchange upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Intercontinental Exchange from Hold to Buy and set a new price target of $188.00

    3/6/26 8:18:46 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Intercontinental Exchange upgraded by Raymond James with a new price target

    Raymond James upgraded Intercontinental Exchange from Outperform to Strong Buy and set a new price target of $210.00

    10/13/25 8:40:25 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    The Benchmark Company initiated coverage on Abbott Labs with a new price target

    The Benchmark Company initiated coverage of Abbott Labs with a rating of Buy and set a new price target of $145.00

    10/10/25 8:35:50 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $ICE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Starks Daniel J bought $1,087,331 worth of Common shares without par value (10,000 units at $108.73), increasing direct ownership by 0.15% to 6,738,817 units (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    2/6/26 8:04:16 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CHAIRMAN AND CEO Ford Robert B bought $2,013,967 worth of Common shares without par value (18,800 units at $107.13) (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    1/26/26 8:02:24 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $ICE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NYSE Content Update: The Hill & Valley Forum Convenes Leaders in Washington

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, March 24, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on March 24thMarkets are little changed after coming off a winning session on Monday, amid optimism that a resolution to the Iran conflict could be in sight.The 'Where You Work Matters' list, featuring nearly 200 NYSE-listed companies, has been revealed and Rajiv Chandrasekaran of the Schultz Family Foundation will join NYSE L

    3/24/26 8:55:00 AM ET
    $BMA
    $DAN
    $ICE
    Commercial Banks
    Finance
    Auto Parts:O.E.M.
    Consumer Discretionary

    John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening

    Potentially awkward conversations and 90s nostalgia combine to drive accessible screening for adults 45+Learn more at Cologuard.com/TheTalkABBOTT PARK, Ill., March 24, 2026 /PRNewswire/ -- Abbott (NYSE:ABT) today announced a new campaign encouraging people to stop avoiding awkward conversations about colorectal cancer. The company is reuniting beloved sitcom family members, John Stamos and Jodie Sweetin, for "The (Second) Talk" campaign – because when it comes to colon cancer screening, even adults need another trusted adult for advice."The (Second) Talk," brings back TV's favorite uncle and niece duo to spoof "the talk" for a nostalgic, sitcom-style skit to remind people that while colon ca

    3/24/26 8:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New York Stock Exchange and Securitize Agree to Memorandum of Understanding to Support Tokenized Securities

    Collaboration focuses on digital transfer agent infrastructure and broker-dealer participation to support issuer-sponsored tokenized securities on NYSE's Digital Trading Platform The New York Stock Exchange (NYSE), part of Intercontinental Exchange, Inc. (NYSE:ICE), one of the world's leading providers of financial market technology and data powering global capital markets, and Securitize, the world's leader in tokenizing real-world assets, today announced a collaboration to support the development of tokenized securities markets, with Securitize named as the first digital transfer agent eligible to mint blockchain-native securities for corporate or ETF issuers on the upcoming NYSE-affili

    3/24/26 8:00:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $ABT
    $ICE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 24, 2023 - FDA Approves New Therapy for Rare Form of Blood Cancers Called Myelodysplastic Syndromes

    For Immediate Release: October 24, 2023 Today, the U.S. Food and Drug Administration approved Tibsovo (ivosidenib) for the treatment of adult patients with relapsed or refractory (R/R) myelodysplastic syndromes (MDS) with an isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test. This is the first targeted therapy approved for this indication. The agency also approved the Abbott RealTime

    10/24/23 3:52:17 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $ICE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President Jackson Benjamin exercised 2,724 shares at a strike of $110.05, increasing direct ownership by 2% to 164,163 units (SEC Form 4)

    4 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    3/12/26 4:30:06 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 4 filed by Intercontinental Exchange Inc.

    4 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    3/11/26 4:30:06 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Senior Vice President Shroff Eric covered exercise/tax liability with 1,384 units of Common shares without par value and sold $81,946 worth of Common shares without par value (709 units at $115.58), decreasing direct ownership by 5% to 39,164 units (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    3/3/26 8:20:08 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $ICE
    SEC Filings

    View All

    SEC Form S-8 filed by Abbott Laboratories

    S-8 - ABBOTT LABORATORIES (0000001800) (Filer)

    3/23/26 5:30:42 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Abbott Laboratories filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - ABBOTT LABORATORIES (0000001800) (Filer)

    3/23/26 8:54:17 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form PRE 14A filed by Intercontinental Exchange Inc.

    PRE 14A - Intercontinental Exchange, Inc. (0001571949) (Filer)

    3/20/26 4:30:23 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $ABT
    $ICE
    Financials

    Live finance-specific insights

    View All

    Abbott completes acquisition of Exact Sciences

    Establishes Abbott as a leader in fast-growing cancer screening and diagnostics segmentsAdvances Abbott's mission to make healthcare more accessible and give people more control over their healthABBOTT PARK, Ill., March 23, 2026 /PRNewswire/ -- Abbott (NYSE:ABT) today announced it has completed the acquisition of Exact Sciences, establishing Abbott as a leader in fast-growing cancer screening and diagnostics segments and enabling the company to serve millions of additional people. "Abbott's global scale, track record of operational and commercial excellence and work with healthcare systems around the world will expand access to important tools for early cancer detection and personalized trea

    3/23/26 8:50:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NYSE Content Update: Two MSCI Indexes to Begin Trading on NYSE Arca Options

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 25, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on February 25thEquities are higher Wednesday morning as Nvidia prepares to release its fourth quarter earnings after market close.MSCI Emerging Markets Index Options and MSCI EAFE Index Options are set to begin trading on NYSE Arca Options today under the ticker symbols MXEF and MXEADynatrace (NYSE:DT) CEO Rick McConnell will

    2/25/26 8:55:00 AM ET
    $BMY
    $DT
    $ICE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology

    Abbott declares 409th consecutive quarterly dividend

    ABBOTT PARK, Ill., Feb. 20, 2026 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 63 cents per share. This marks the 409th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable May 15, 2026, to shareholders of record at the close of business on April 15, 2026.Abbott has increased its dividend payout for 54 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.About Abbott:Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio o

    2/20/26 11:38:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $ICE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Abbott Laboratories (Amendment)

    SC 13G/A - ABBOTT LABORATORIES (0000001800) (Subject)

    2/13/24 4:55:58 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Intercontinental Exchange Inc. (Amendment)

    SC 13G/A - Intercontinental Exchange, Inc. (0001571949) (Subject)

    2/13/24 1:23:13 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by Abbott Laboratories (Amendment)

    SC 13G/A - ABBOTT LABORATORIES (0000001800) (Subject)

    2/9/23 10:54:50 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $ICE
    Leadership Updates

    Live Leadership Updates

    View All

    NYSE Content Update: AI Data Platform DDN Appoints Guido Torrini as Finance Chief

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 24, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on February 24thEquities are little changed this morning after President Trump's 10% global levies officially went into effect early today.H&R Block CEO Curtis Campbell will join NYSE Live today to share why this tax season is particularly 'complex.'Amer Sports says it delivered 27% revenue growth in 2025 during its Q4 earnings

    2/24/26 8:55:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    NYSE Content Update: USA TODAY Co. Rings Opening Bell to Celebrate Rebrand

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 17, 2026 /CNW/ --  The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on February 17thStocks are down Tuesday morning ahead of a shortened trading week after markets were closed yesterday for Presidents Day.Leaders from Payments platform, Bolt, and Digital Identity Company, Socure, are set to join NYSE Live to talk about their latest collaboration that they believe will Supercharge E-commerce id

    2/17/26 8:55:00 AM ET
    $ICE
    $TDAY
    Investment Bankers/Brokers/Service
    Finance
    Newspapers/Magazines
    Consumer Discretionary

    Nanhua Singapore Becomes Exchange and Clearing Member of ICE Futures Singapore and ICE Clear Singapore

    Intercontinental Exchange (NYSE:ICE), a leading global provider of technology and data, today announced that Nanhua Singapore Pte. Ltd. (Nanhua Singapore) has become a member of ICE Futures Singapore and ICE Clear Singapore. With these appointments, Nanhua Singapore can trade and clear its own business and clients' business. "We are pleased to join ICE in Singapore, as becoming a member allows Nanhua Singapore to strengthen our trading and global clearing capabilities, providing our clients with expanded opportunities in international markets," said Zheng Peiyuan, Chief Executive Officer, Nanhua Singapore. "This membership underscores our commitment to delivering reliable and efficient se

    12/21/25 8:00:00 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance